Showing results (731-740 of 779) with videos related to
Sort By:
Pageof 78
JACC. Advances|April 28, 2026
Postdilation Strategies Following Provisional Stenting of Left Main Coronary Bifurcations: Insights From Patient-Specific Computational SimulationsShijia Zhao, Wei Wu, Changkye Lee, et al.The American Journal of Cardiology|May 19, 2020
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)Jaya Chandrasekhar, Samantha Sartori, Melissa B Aquino, et al.European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKDPayam Dehghani, Davide Cao, Usman Baber, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2020
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO CollaborationJaya Chandrasekhar, Doreen Zeebregts, Deborah N Kalkman, et al.American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.Journal of the American College of Cardiology|August 17, 2023
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary InterventionsGuiomar Mendieta, Shamir Mehta, Usman Baber, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 18, 2022
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG studyGennaro Sardella, Frans J Beerkens, George Dangas, et al.JAMA Cardiology|June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Rafael Harari, Usman Baber, et al.JACC. Cardiovascular Interventions|March 21, 2020
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery OverlapGilbert H L Tang, Syed Zaid, Andreas Fuchs, et al.Cardiovascular Drugs and Therapy|January 30, 2021
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO CollaborationJaya Chandrasekhar, Vera C de Winter, Deborah N Kalkman, et al.Pageof 78